Cited by 23Reproductive Biology and FertilityOvarian cancer diagnosis and treatmentReproductive biology and impacts on aquatic species

Establishment of a pediatric ovarian and testicular cryopreservation program for malignant and non-malignant conditions: the Mayo Clinic experience

Joshi, Vidhu B., Behl, Supriya, Pittock, Siobhan T., Arndt, Carola A.S., Zhao, Yulian, Khan, Zaraq, Granberg, Candace F., Chattha, Asma·2021·Journal of Pediatric and Adolescent Gynecology

Abstract

Study objectives To describe the structure of a pediatric fertility preservation (FP) program and to share safety and patient satisfaction data.Design The FP program operates under prospective research protocols approved by the Mayo Clinic Institutional Review Board (IRB).Setting The FP program is a multidisciplinary effort between pediatric gynecology, reproductive endocrinology, pediatric urology, pediatric surgery, and laboratory medicine.Participants The FP program enrolls patients between 0-17 years of age who have been diagnosed with a fertility-threatening condition and/or are scheduled to undergo gonadotoxic treatment.Interventions FP is offered in the form of ovarian tissue cryopreservation (OTC) and testicular (TTC) tissue cryopreservation.Main outcome measures The outcome measures are the safety of the procedure and results of patient surveys conducted by phone using a standard list of questions to assess attitudes towards FP.Results To date, we have enrolled 38 OTC and 37 TTC patients. The median age (range) of OTC and TTC patients was 11 years (0.83-17 years) and 10 years (0.92-17 years) at the time of enrollment, respectively. Childhood cancers currently represent 88% of the fertility-threatening diagnoses. Meanwhile, patients with non-malignant conditions include those with gender dysphoria, aplastic anemia, and Turner's syndrome. To date, no serious adverse events (SAEs) have been reported following surgery. According to n = 34 one-year follow-ups, 100% of parents felt that FP was a good decision.Conclusion Consistent with the literature, our data suggests FP is safe and improves the quality of care provided to pediatric patients for their fertility-threatening diagnoses and/or treatments.Trial registration NCT02872532, NCT02646384.

Integrity signals

Registry

Crossref · 10.1016/j.jpag.2021.04.006

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Joshi, V. B., Behl, S., Pittock, S. T., Arndt, C. A. S., Zhao, Y., Khan, Z., Granberg, C. F., & Chattha, A.
Affiliations
Mayo Clinic (US)
Corresponding author
Chattha, Asma
Venue
Journal of Pediatric and Adolescent Gynecology
Publisher
Elsevier BV
Published
2021-10
Volume
34
Issue
5
Pages
673-680
ISSN
  • 0932-8610 (ISSN-L)
  • 1083-3188
OpenAlex
W3158052626
Cited by
23
References
61
Citations by year
2026: 1 · 2025: 4 · 2024: 8 · 2023: 6 · 2022: 2 · 2021: 2
FWCI
3.91
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Pediatric and Adolescent Gynecology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Biology and Fertility
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian cancer diagnosis and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Reproductive biology and impacts on aquatic species
Keywords
ovarian tissue cryopreservation, testicular tissue cryopreservation, gonadotoxic therapy, childhood cancer, patient safety, patient satisfaction, gender dysphoria, aplastic anemia, Turner syndrome
MeSH terms
Child, Female, Humans, Male, Neoplasms, Ovary, Prospective Studies, Testis, Cryopreservation, Fertility Preservation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review